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Background: When calculating the number of deaths attributable to alcohol consumption (i.e., the number of
deaths that would not have occurred if everyone was a lifetime abstainer), alcohol consumption is most often
modelled using a capped exposure distribution so that the maximum average daily consumption is 150 grams of
pure alcohol. However, the effect of capping the exposure distribution on the estimated number of alcohol-
attributable deaths has yet to be systematically evaluated. Thus, the aim of this article is to estimate the number of
alcohol-attributable deaths by means of a capped and an uncapped gamma distribution and capped and
uncapped relative risk functions using data from the European Union (EU) for 2004.
Methods: Sex- and disease-specific alcohol relative risks were obtained from the ongoing Global Burden of Disease,
Comparative Risk Assessment Study. Adult per capita consumption estimates were obtained from the Global
Information System on Alcohol and Health. Data on the prevalence of current drinkers, former drinkers, and lifetime
abstainers by sex and age were obtained from various population surveys. Alcohol-attributable deaths were
calculated using Alcohol-Attributable Fractions that were calculated using capped (at 150 grams of alcohol) and
uncapped alcohol consumption distributions and capped and uncapped relative risk functions.
Results: Alcohol-attributable mortality in the EU may have been underestimated by 25.5% for men and 8.0% for
women when using the capped alcohol consumption distribution and relative risk functions, amounting to the
potential underestimation of over 23,000 and 1,100 deaths in 2004 in men and women respectively. Capping of the
relative risk functions leads to an estimated 9,994 and 468 fewer deaths for men and for women respectively when
using an uncapped gamma distribution to model alcohol consumption, accounting for slightly less than half of the
potential underestimation.
Conclusions: Although the distribution of drinkers in the population and the exact shape of the relative risk
functions at large average daily alcohol consumption levels are not known, the findings of our study stress the
importance of conducting further research to focus on exposure and risk in very heavy drinkers.
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Alcohol consumption is one of the most important risk
factors for the global burden of disease, and was the third
leading cause of Disability Adjusted Life Years lost (bur-
den of disease) globally in 2004 and 2010 [1-3]. Generally,
in calculating the number of deaths attributable to alcohol
consumption, the most conservative approaches have
been used [4,5]. For example, the method used in the
2005/2010 Comparative Risk Analysis (CRA) as part of
the Global Burden of Disease (GBD) study to estimate
Alcohol-Attributable Fractions (AAFs) (defined as the
proportion of deaths that would not have occurred if
everyone was a lifetime abstainer; for background on at-
tributable fractions see [6,7] for unadjusted attributable
fractions, and [8] for adjusted attributable fractions) as-
sumed that a person could consume a maximum of 150
grams of pure alcohol per day [9]. The approach of
capping the continuous alcohol exposure distribution has
also been used for country level and regional alcohol-
attributable burden of disease studies [10-13].
To mathematically achieve a maximum alcohol con-
sumption cap of 150 grams of alcohol per day, the gamma
distribution used to model the consumption of a popula-
tion of current drinkers is normalized to integrate to 1
when the gamma distribution is integrated from >0 to 150
grams of pure alcohol per day (for a detailed description
of this methodology see [14,15]). While data have shown
that some people may drink more than 150 grams of alco-
hol on any given day, it seemed implausible that this level
of consumption could be maintained during the biological
latency period where alcohol consumption leads to the in-
cidence and development of a disease, and mortality from
the disease. However, there is evidence that some people,
especially those with alcohol dependence, continue to
drink at high levels for prolonged periods of time. For ex-
ample, a 20-year cohort study of alcohol-dependent pa-
tients who had received treatment for their alcoholism
found that some participants consumed large average
amounts of alcohol over prolonged periods of time. Dur-
ing the times in the cohort study when participants were
drinking, average alcohol consumption per day was ap-
proximately 140 grams per participant (for a description
of the cohort and main results see [16,17]), thus making it
probable that the heaviest drinkers consumed above 150
grams of pure alcohol during the biological latency period.
In order to test the effect of capping the alcohol con-
sumption distribution, unsystematic sensitivity analyses
that calculated AAFs had been performed for a limited
number of alcohol-related diseases [9,14]. These sensitivity
analyses indicated that there was not a large difference in
the calculated AAFs when alcohol consumption was mod-
elled using a capped or an uncapped distribution. These
analyses had been, however, very limited, in that they only
addressed breast cancer, pancreatitis and diabetes.Capping of the gamma distribution changes the nature
of the distribution. The domain of the gamma distribu-
tion is 0 to ∞; normalization of the gamma distribution
changes this domain from 0 to 150 and causes changes
to the distribution’s basic characteristics by altering the
properties of the shape and scale parameters. Although
changes in the gamma distribution after normalization
are relatively small, the alteration of the distribution
leads to small mathematical inaccuracies [18].
The second conservative assumption generally fol-
lowed when calculating the number of deaths attribu-
table to alcohol consumption is that the Relative Risks
(RRs) do not increase past a large value as consumption
increases, with most RR functions being capped after
consumption of 120 to 150 grams of alcohol per day;
however, in some cases, a lower alcohol consumption
limit has been applied to the RR functions [19]). These
RR limits were based on the greatest average daily alco-
hol consumption reported in the underlying cohort
studies used in the meta-analyses to calculate the alcohol
RR functions. Capping was performed as RR functions
obtained from meta-regression are not considered to be
valid when consumption is greater than the greatest
average daily alcohol consumption reported in these co-
hort studies (see [20]).
Since the above-noted conservative assumptions have
not been previously explored systematically, the aim of
our study was to systematically examine the effect of
capping the alcohol consumption distribution and the
RR functions using alcohol consumption data and mor-
tality data from the EU for 2004.
Methods
Exposure estimates
Average daily consumption of alcohol for 2005 (the clo-
sest year to 2004 for which data were available) was cal-
culated based on a triangulation of survey data and per
capita consumption data estimates. Total adult (15 years
of age and older) per capita consumption of alcohol was
calculated by adding the estimates of recorded, unre-
corded, and tourist adult per capita consumption. All
data on recorded (based on official statistics of taxes,
sales and/or production, imports and exports), unrecorded
(based on population survey data, government monitoring
data and expert judgement) and tourist consumption (cal-
culated for countries where there was significant cross
border trade (Estonia and Moldova) or countries where
the number of tourists that visited a country was greater
that the population of the country) were obtained from
the Global Information System on Alcohol and Health
database (http://apps.who.int/globalatlas/default.asp; see
also [21]). The Global Information System collects data
via surveys to governments and experts; definitions of
the categories described above and the methodology for
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apps.who.int/globalatlas/default.asp). For 2010 alcohol ex-
posure estimates by country see [22].
Risk relations
Disease categories where alcohol consumption had a causal
impact were identified via standardized methodology [23].
Sources for alcohol-related RR functions by International
Classification of Diseases (ICD-10) codes are outlined in
Additional file 1: Web Appendix 1. The RR functions and
diseases modelled in this paper were based on those in the
2005/2010 CRA for alcohol [3]. The RRs, in most cases,
were obtained from meta-analyses reporting a continuous
RR function by dose of exposure, i.e., by average daily
grams of ethanol consumed (except for tuberculosis and
myocardial infarction where categorical risk estimates were
used). RRs for current drinkers and former drinkers were
obtained from the same meta-analyses (see Additional file
1: Web Appendix 1 for the specific meta-analyses used).
Relative risk function capping
AAFs were calculated using capped and uncapped RR
functions. To prevent unrealistic RR functions, the
majority of uncapped RR functions were capped after
consumption of 300 grams of alcohol per day, and were
changed to linear functions after a consumption of 150
grams of alcohol per day (see Additional file 2: Web
Appendix 2). The choice of capping or linearizing the
RR function after 150 g/day was made based on the
slope of the function at high consumption. If the slope
was increasing rapidly, the function was capped right
away, if not, it was linearized first.
Mortality data
Data on the number of deaths by cause, sex, age and
country were obtained from the 2004 GBD study [24].
Alcohol exposure modelling methodology
The prevalence of average daily consumption of alcohol
at the population level has been found to be modelled
best using the gamma distribution [9]. The gamma distri-
bution has been shown to provide a good fit with alcohol-
drinking population data and is very adaptable [9,14]. The
gamma distribution can be expressed as follows:
Gamma x; κ; θð Þ ¼ xκ1 e
x=θ
θκΓ κð Þ for x; κ; θ > 0
where κ represents the shape parameter, θ represents the
scale parameter, and Γ(κ) is the gamma function and is
calculated as follows:
Γ κð Þ ¼
Z 1
>0
tκ1etdtThe gamma distribution displays some properties that




and κ ¼ μ
2
σ2
Also, the mean of the gamma distribution is equal to
the empirical mean.
Previous research examining the relationship between
mean alcohol consumption and the standard deviation
of the gamma distribution using data from 851 datasets
found a strong linear relationship between the mean and
the standard deviation of the alcohol consumption
gamma distribution [9]. The standard deviation of the
gamma distribution for any population (and any age
group within a population) can be calculated as follows:
For men:
σmen ¼ 1:171⋅ μmen
For women:
σwomen ¼ 1:258 ⋅ μwomen
Thus, only data on adult per capita consumption and
the prevalence of current drinkers are needed in order
to model the alcohol consumption distribution [5,9,14].
To account for alcohol that is not consumed due to
spillage, breakage and waste, and undercoverage in the
medical epidemiology studies that are used to calculate
alcohol RRs, 80% of total per capita consumption is
used when empirically modelling alcohol consumption
using the gamma distribution (for a detailed discus-
sion see [5]).
The alcohol consumption distribution cap of 150
grams per day was implemented by normalizing the
gamma distribution, so that when consumption was in-
tegrated from >0 to 150 grams of alcohol per day, the in-
tegral would be equal to 1. It should be noted that the
use of the notation >0 indicates the exclusion of 0 in the
integration, as an average consumption of 0 grams per
day does not qualify a person as a drinker. This, how-
ever, leaves no mathematical artifact, as the gamma dis-
tribution at 0 always equals 0.
Modelling alcohol-attributable deaths
The AAFs were calculated for the total number of deaths
attributable to alcohol consumption according to CRA
methodology [3], and, thus, calculated the number of
deaths that would not be present under the counterfactual
scenario that everyone was a lifetime abstainer (thus, life-
time abstainers were used as the reference category for
risks). The decision to use lifetime abstention as the refer-
ence follows the earlier CRAs for alcohol (see [3,5]; see
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Pcurrent xð ÞRRcurrent xð Þdx
where Pabstainer represents the prevalence of lifetime ab-
stainers, RRabstainer represents the relative risk for lifetime
abstainers (equals 1 as lifetime abstainers are the reference
group), Pformer represents the prevalence of former
drinkers, Pcurrent(x) represents the prevalence of current
drinkers who on average consume × grams of alcohol per
day, RRformer is the relative risk for a disease for a former
drinker, and RRcurrent(x) is the relative risk for a disease
for a current drinker who on average drinks × grams of al-
cohol per day. In the uncapped scenario, the integral
would be evaluated between 0 and infinity. The separation
between lifetime abstainers and former drinkers was based
on the different associated risks. Former drinkers usually
have higher risks for disease and mortality (see [23] for an
overview of RRs for former drinkers for different disease
categories), as a substantial number of former drinkers
have quit drinking for health reasons (see the so-called
sick quitter hypotheses, e.g., [26,27]).
The above attributable fraction is based on continuous
exposure and risk functions. Such an approach is
deemed, in general, to be advantageous compared to cat-
egorical distributions [28,29] because it involves no loss
of information. However, for alcohol, the difference be-
tween capped distributions and the categorical approach
was not large [14]. In some sense, capping of RRs intro-
duces an element of the categorical approach into the
continuous approach.
Normalization
To assess the changes in the AAFs due to the nor-
malization of the gamma function, we compared the es-
timated number of alcohol-attributable deaths in the EU
for 2004 obtained with a normalized prevalence distribu-
tion (from >0 to 150 grams per day) with those obtained
with a non-normalized prevalence distribution (from
>0 to infinity). To depict the difference in
normalization at higher levels of consumption, we
compared the normalized and non-normalized gamma
distributions for men 15 years of age and older in
Latvia; Latvian men were chosen as the relatively high al-
cohol consumption levels in Latvia make the difference
between the capped and uncapped distributions more
salient.Results
Figure 1 shows the original and the normalized gamma
distributions for men 15 years of age and older in Latvia.
When the gamma distribution is normalized, we ob-
served a higher average daily consumption of alcohol
among current drinkers, resulting in a greater change in
the alcohol consumption distribution when normalized.
However, as displayed in Figure 1, for men aged 15 years
and older in Latvia, the effect of this shift is minimal. As
Latvia has the highest average consumption among
current drinkers in the EU (consumption was 35.8 litres
per current drinker for 2005), the shift in the consump-
tion distribution would be less than that for other EU
countries for 2005.
Table 1 displays the prevalence of average daily alcohol
consumption among current drinkers of >0 to <150 grams
per day, 150 to <200 grams per day, and 200+ grams per
day for the EU in 2005 using an unadjusted alcohol con-
sumption distribution. These numbers stem from an
gamma distribution that was based on the aggregated al-
cohol consumption from all countries in the EU (see also
[30], for details on country distributions). For women, we
found that 99.99% of current drinkers consumed less than
150 grams of alcohol per day and 0.001% consumed
between 150 and <200 grams per day. In the EU in 2005,
98.30% of male current drinkers consumed between >0
and <150 grams of alcohol per day, 1.20% consumed
between 150 and <200 grams per day, and 0.50% con-
sumed 200 grams or more of alcohol per day. The shift in
the mean alcohol consumption is negligible for women.
For men, the normalization of the gamma distribution to
150 grams per day leads to a difference in mean alcohol
consumption downwards of 2.85 grams per day (from
31.97 to 29.12 g/day).
Table 2 outlines the AAFs for men and women in the
EU for 2005 by disease category with the alcohol con-
sumption gamma distribution capped and uncapped,
while keeping the RR functions capped. Table 3 outlines
the AAFs using uncapped RR functions. The change in
the AAFs when capping the alcohol consumption distri-
bution and/or the RR functions is greater for men than
for women. This simply stems from the fact that fewer
women than men drink 150 grams or more of alcohol
per day.
Table 4 outlines the number of deaths by cause and
sex that were attributable to alcohol using a capped and
an uncapped alcohol consumption distribution and an
uncapped RR function. We observed that 24,242 fewer
alcohol-attributable deaths were estimated when the al-
cohol consumption distribution and the RR functions
were capped. Of the 24,242 alcohol-attributable deaths,
95% were in men. This represents a relative difference of
23.1% (25.5% for men and 8.0% for women) in the num-
ber of deaths as compared to the uncapped distribution.
Figure 1 Original and normalized gamma distributions for men in Latvia.
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sex attributable to alcohol consumption using a capped
and an uncapped alcohol consumption distribution and
capped RR functions. We can conclude that of the
24,242 difference in alcohol-attributable deaths that
comes from capping the alcohol consumption distribu-
tion and the RR functions, 43.2% (43.3% for men and
40.8% for women) is due to capping of the RR function.
The majority of the difference in mortality observed
when comparing the capped and uncapped RR functions
(while keeping the alcohol consumption distribution un-
capped) was due to deaths from liver cirrhosis. When
comparing the resulting AAFs and deaths for men and
women estimated using a capped and an uncapped
gamma distribution, there was a greater protective effect
of alcohol consumption observed for the capped distri-
bution when compared to the uncapped distribution (al-
though some estimates seem to be equal, the capped
estimates are lower; however, the difference is not shown
in the number of digits presented for these estimates).
Discussion
The results of our study indicate that for the EU in 2004
there was a substantial difference in the number of esti-
mated alcohol-attributable deaths when either the alco-
hol consumption distribution or the RR functions are
capped. However, it is uncertain if capping leads toTable 1 Prevalence of average daily alcohol consumption
in the European Union
Average daily consumption in grams per day Females Males
>0 to <150 99.99% 98.30%
150 to <200 0.01% 1.20%
200 grams and greater 0.00% 0.50%better estimates of the actual number of alcohol-
attributable deaths as literature on very heavy drinkers
and their resulting increased risk of alcohol-related dis-
eases is scarce. In alcohol epidemiology, cohorts that are
used to measure the underlying risk relationships are
usually selected to maximize the follow-up rate, and,
thus, these cohorts are typically composed of special
populations with comparatively few heavy and virtually
no very heavy drinkers [20,31,32]. Even in cohorts that
are representative of the general population, many heavy
or very heavy drinkers are excluded by study design, as
they are not typically included in the sampling frame
(which often excludes homeless/institutionalized indivi-
duals) or are less likely to respond and participate in
studies when contacted [13].
Studies on the risk of mortality from alcohol-related dis-
eases for people with alcohol dependence (who consume a
large amount of alcohol) do exist, and show a high RR of
mortality for this population; however, these studies do
not provide the underlying alcohol consumption for this
population and, thus, it is impossible to rely on these stud-
ies to improve the RR functions at high alcohol
consumption levels [30,33,34]. Moreover, it is not clear if
alcohol consumption or some co-morbid conditions asso-
ciated with alcohol dependence were responsible for the
high mortality observed in these studies.
Given the uncertainties outlined above, research on
the morbidity and mortality consequences of heavy and
very heavy drinking is urgently needed to adequately
assess the burden of disease attributable to alcohol
consumption. The results of these required studies
ideally will determine whether the high consumption
levels observed in studies of individuals with alcohol de-
pendence can, in fact, be sustained over long periods of
time, and will determine the risk relationships between
Table 2 AAFs for males and females in the European
Union, using a capped and an uncapped gamma
distribution, and with capped relative risk functions
Females Males
Cause of death Capped Uncapped Capped Uncapped
Oral cavity and pharynx
cancer
26.3% 26.3% 53.0% 55.5%
Esophageal cancer 15.1% 15.2% 34.8% 39.4%
Colorectal cancer 5.2% 5.2% 7.9% 8.7%
Liver cancer 9.0% 9.0% 17.5% 18.7%
Breast cancer 10.8% 10.8% 0.0% 0.0%
Epilepsy 14.7% 14.7% 33.5% 40.5%
Lower respiratory
infections
7.0% 7.0% 13.2% 14.8%
Stroke −1.1% −0.9% 10.4% 12.8%
Hypertension 8.0% 8.3% 23.9% 28.0%
Liver cirrhosis 49.3% 49.9% 71.7% 85.2%
Diabetes −6.4% −6.2% −1.4% 4.2%
Tuberculosis 10.3% 10.3% 31.7% 32.7%
Ischemic heart disease −7.2% −7.2% −11.2% −11.0%
Motor vehicle accidents 9.0% 9.1% 14.2% 14.7%
Suicide 9.0% 9.1% 14.2% 14.7%
Other injuries 9.0% 9.1% 14.2% 14.7%
Table 3 AAFs for males and females in the European
Union, using a capped and an uncapped gamma
distribution, and with uncapped relative risk functions
Females Males
Cause of death Capped Uncapped Capped Uncapped
Oral cavity and pharynx
cancer
26.3% 26.3% 53.0% 55.8%
Esophageal cancer 15.1% 15.2% 34.8% 41.2%
Colorectal cancer 5.2% 5.2% 7.9% 9.0%
Liver cancer 9.0% 9.0% 17.5% 18.9%
Breast cancer 10.8% 10.8% 0.0% 0.0%
Epilepsy 14.7% 14.7% 33.5% 44.8%
Lower respiratory
infections
7.0% 7.0% 13.2% 15.4%
Stroke −1.1% −0.8% 10.4% 13.8%
Hypertension 8.0% 8.4% 23.9% 30.1%
Liver cirrhosis 49.3% 50.2% 71.7% 93.4%
Diabetes −6.4% −6.2% −1.4% 25.3%
Tuberculosis 10.3% 10.3% 31.7% 32.7%
Ischemic heart disease −7.2% −7.2% −11.2% −11.0%
Motor vehicle accidents 9.0% 9.1% 14.2% 14.7%
Suicide 9.0% 9.1% 14.2% 14.7%
Other injuries 9.0% 9.1% 14.2% 14.7%
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(for a first attempt at estimating these risk relationships
see [33]).
The estimated number of alcohol-attributable deaths
due to liver cirrhosis was the category that was most af-
fected by the capping of the RR functions. Liver cirrho-
sis, in particular, is associated with longer term heavy
drinking, with some studies finding that overall exposure
to alcohol is the most important factor in developing
this disease [35,36]. However, the exact form of the risk
function for very heavy drinkers is still unknown, as is
whether the RR function for liver cirrhosis in fact con-
tinues to increase exponentially with increasing exposure
at very high alcohol consumption levels. Capping the
gamma distribution also resulted in a greater estimated
effect of alcohol consumption on ischemic heart disease,
stroke and diabetes. This greater protective effect was
due to the normalization of the gamma distribution
resulting in a greater prevalence of moderate drinkers
(drinkers who experience a protective effect for the
aforementioned diseases) when compared to the un-
capped distribution. These results contrast with earlier
non-systematic analyses of the effects of capping which
showed very little difference between the AAF estimates
using capped and uncapped models [9]. This contrast is
easily explained when considering that the diseases that
make up most of the difference have not been studied inprevious analyses. In the previous analyses, Kehoe and
colleagues only analysed the effects of capping the
gamma distribution at 300 grams per day (where most
studies have used a cap of 150 grams per day) and only
looked at the effect of capping the gamma distribution
of the estimated AAF for diabetes, breast cancer and
pancreatitis [9].
Capping seems to be potentially problematic only in
the male population, due to the larger proportion of
men, as compared to women, who drink over 150 grams
of alcohol per day. The 150 g/day cap is not sex specific.
This lack of a sex specific cap creates a problem as men
with alcohol use disorders (heavy consumers of alcohol)
usually consume more alcohol than do women with al-
cohol use disorders [37]. Thus, the 150 g/day cap theor-
etically leads to a larger bias when estimating the
alcohol-attributable burden of disease for men as com-
pared to the bias the cap theoretically leads to when esti-
mating the alcohol-attributable burden of disease for
women. It could be argued that gender specific capping
could lead to more accurate results; however, as men-
tioned previously, RR data for sustained very high alco-
hol consumption are largely unavailable, which is an
issue that should also be addressed.
This study has limitations in terms of the data used to
compare the estimated alcohol-attributable mortality
when using a capped and an uncapped alcohol
Table 4 Alcohol-attributable deaths for people aged
15 years and older in the European Union calculated
using capped (at 150 grams per day) and uncapped
alcohol consumption distributions and uncapped relative
risk functions
Females Males
Cause of death Capped Uncapped Capped Uncapped
Oral cavity and pharynx
cancer
1,719 1,721 12,935 13,563
Esophageal cancer 1,235 1,238 8,492 9,632
Colorectal cancer 4,008 4,012 6,884 7,570
Liver cancer 1,459 1,460 5,259 5,619
Breast cancer 11,048 11,073 0 0
Epilepsy 472 473 1,650 1,993
Lower respiratory
infections
5,297 5,304 8,171 9,138
Stroke −3,507 −2,895 22,803 28,097
Hypertension 5,193 5,396 9,285 10,878
Liver cirrhosis 13,840 14,019 41,721 49,549
Diabetes −3,995 −3,893 −637 1,877
Tuberculosis 238 238 1,830 1,889
Ischemic heart disease −30,117 −30,113 −50,684 −49,698
Motor vehicle accidents 1,067 1,067 5,386 5,551
Suicide 1,379 1,380 6,990 7,203
Other injuries 5,006 5,008 10,467 10,787
Total deaths 14,342 15,488 90,552 113,648
Table 5 Alcohol-attributable deaths for people aged
15 years and older in the European Union calculated
using capped (at 150 grams per day) and uncapped
alcohol consumption distributions and capped relative
risk functions
Females Males
Cause of death Capped Uncapped Capped Uncapped
Oral cavity and pharynx
cancer
1,719 1,721 12,935 13,499
Esophageal cancer 1,235 1,238 8,492 9,206
Colorectal cancer 4,008 4,011 6,884 7,351
Liver cancer 1,459 1,460 5,259 5,553
Breast cancer 11,048 11,068 0 0
Epilepsy 472 473 1,650 1,802
Lower respiratory
infections
5,297 5,303 8,171 8,790
Stroke −3,507 −3,189 22,803 26,067
Hypertension 5,192 5,322 9,285 10,129
Liver cirrhosis 13,840 13,926 41,721 45,213
Diabetes −3,995 −3,893 −637 312
Tuberculosis 238 238 1,830 1,889
Ischemic heart disease −30,117 −30,113 −50,684 −49,698
Motor vehicle accidents 1,067 1,067 5,386 5,551
Suicide 1,379 1,380 6,990 7,203
Other injuries 5,006 5,008 10,467 10,787
Total deaths 14,341 15,020 90,552 103,654
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limited by the absence of age-specific estimates for the
EU due to a lack of age-specific reported information on
the prevalence of current drinkers, former drinkers, and
lifetime abstainers, and the relative amount of alcohol
consumed. Additionally, data on the uncertainty of the
RR functions after 150 g/day were in most cases not
available, and, thus, it was impossible to calculate the
95% confidence intervals for the burden of disease at-
tributable to alcohol consumption. The limitations of
this study which are inherent to all burden of alcohol
studies include inaccuracies with alcohol exposure data,
risk estimates (discussed previously), and mortality data.
The accuracy of the measurement of lifetime abstainers
in a population and in the observational studies that
were used in the meta-analyses that the RR estimates
were based upon are subject to multiple biases and often
lifetime abstainers are misclassified as former drinkers
[38]. Alcohol drinking status estimates are also limited
by the biases introduced by the surveys that measure
them [13]. The alcohol consumption estimates (i.e. per
capita consumption of alcohol) are subject to random
error with data on unrecorded adult per capita con-
sumption and tourist per capita consumption havingsubstantially more uncertainty than does recorded con-
sumption [39]. Thus for countries as recorded adult per
capita consumption and tourist per capita consumption
proportionally make up more of total adult per capita
consumption the larger the random error will be for the
measured total adult per capita consumption. Addition-
ally, the categorization of deaths by cause is often
miscoded or coded in junk categories [40,41]. Although
these biases will affect the measured difference in mortal-
ity when using a capped and an uncapped alcohol con-
sumption distribution, this paper demonstrates that there
is a need to determine an accurate cap as there is a large
difference between the calculated alcohol-attributable
mortality when using a capped and an uncapped distribu-
tion. As this analysis does not assess the goodness of fit of
alcohol consumption distribution models and does not
adjust for any confounding factors, the numbers presented
in this manuscript should not be taken as “true” estimates
as they are only used to demonstrate the effect of capping
the alcohol consumption distribution on the estimated
alcohol-attributable mortality.
Future research should focus on determining an accur-
ate alcohol consumption cap rather than assessing the
impact of these biases on the differences between
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tions; once an accurate alcohol consumption cap is deter-
mined, it should always be used.
Conclusion
Capping of the alcohol consumption distribution or of
the RR functions is a conservative approach when es-
timating the number of deaths attributable to alcohol
consumption and may lead to an underestimation of
alcohol-attributable mortality. Further research is neces-
sary to determine the extent to which the capping of al-
cohol consumption and RR functions leads to an
underestimation of the actual number of alcohol-
attributable deaths.
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